Enantis s.r.o. is a private company founded in 2006 as the first biotechnology spin-off from Masaryk University in Brno, Czech Republic. Our premises are located at INBIT, biotechnology center operated by JIC and located on Masaryk University’s campus. We closely collaborate with Loschmidt Laboratories and other research institutions.

Our expertise is based on vast experience in protein science and state-of-the-art software tools. A combination which enables us to provide powerful and unique protein optimization services to our clients.

We’re also responsible for the production and sale of novel proteins. Our R&D activities are predominantly focused on the family of fibroblast growth factors (FGFs). The goal is to improve the poor stability of FGFs for therapeutic use. Where FGF2 is concerned, we are already in the preclinical testing phase and are on the way to clinical phases.

We have multiple license agreements in place for the use of FGF2-STAB in the field of stem cell cultivation. Press releases here and here.

Among thousands of applicants from all across Europe, we were the first Czech biotech company to receive both phase 1 and phase 2 of prestigious Horizon 2020 SME Instrument grant.

Since 2019, Enantis is proud to be ISO 9001:2016 certified for the quality management system in the field of research, development and production of proteins.

Meet us